Tivity Health Inc (NASDAQ:TVTY)’s stock price shot up 22.9% during trading on Wednesday . The company traded as high as $6.28 and last traded at $7.02, 181,538 shares traded hands during trading. A decline of 94% from the average session volume of 3,161,660 shares. The stock had previously closed at $5.71.
A number of brokerages have recently commented on TVTY. Cantor Fitzgerald downgraded Tivity Health from an “overweight” rating to a “neutral” rating and cut their price objective for the company from $40.00 to $17.00 in a research report on Thursday, February 20th. Zacks Investment Research upgraded Tivity Health from a “sell” rating to a “hold” rating in a research report on Friday, February 21st. Credit Suisse Group reiterated a “hold” rating and set a $11.00 price objective on shares of Tivity Health in a research report on Monday, March 16th. ValuEngine downgraded Tivity Health from a “sell” rating to a “strong sell” rating in a research report on Tuesday. Finally, SunTrust Banks downgraded Tivity Health from a “buy” rating to a “hold” rating and set a $15.00 price objective for the company. in a research report on Thursday, February 20th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $18.91.
The firm’s 50 day simple moving average is $12.91 and its 200-day simple moving average is $17.90. The company has a debt-to-equity ratio of 4.62, a quick ratio of 0.86 and a current ratio of 1.11. The company has a market capitalization of $276.56 million, a price-to-earnings ratio of -1.16, a P/E/G ratio of 0.46 and a beta of 1.56.
In related news, Director Kevin Wills purchased 20,000 shares of the company’s stock in a transaction dated Wednesday, February 26th. The shares were acquired at an average cost of $12.07 per share, with a total value of $241,400.00. Following the completion of the purchase, the director now owns 53,143 shares of the company’s stock, valued at approximately $641,436.01. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Sara Finley purchased 2,500 shares of the company’s stock in a transaction dated Thursday, March 5th. The stock was bought at an average cost of $11.63 per share, for a total transaction of $29,075.00. Insiders bought 26,565 shares of company stock worth $319,255 over the last ninety days. 1.64% of the stock is currently owned by company insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Norges Bank acquired a new position in Tivity Health during the fourth quarter worth $14,320,000. Parametric Portfolio Associates LLC increased its position in Tivity Health by 91.2% during the third quarter. Parametric Portfolio Associates LLC now owns 783,794 shares of the company’s stock worth $13,035,000 after buying an additional 373,782 shares during the last quarter. Phocas Financial Corp. acquired a new position in Tivity Health during the third quarter worth $3,703,000. Alliancebernstein L.P. increased its position in Tivity Health by 196.6% during the fourth quarter. Alliancebernstein L.P. now owns 222,725 shares of the company’s stock worth $4,531,000 after buying an additional 147,630 shares during the last quarter. Finally, State of New Jersey Common Pension Fund D acquired a new position in Tivity Health during the fourth quarter worth $2,277,000.
Tivity Health Company Profile (NASDAQ:TVTY)
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.
See Also: Gross Domestic Product (GDP)
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.